January 21, 2021
UC research, published in JAMA Oncology, shows that chemotherapy before surgery for some pancreatic cancer patients may not improve survival rates.
January 27, 2021
University of Cincinnati researchers have tested a new combination therapy that showed reduced growth of head and neck cancer in an animal-based study.
January 22, 2021
Researchers at the University of Cincinnati have tested a new combination therapy in head and neck cancer animal models to see if they could find a way to make an already effective treatment even better.
February 8, 2021
University of Cincinnati researchers have shown that completely halting a cell recycling process in a very aggressive form of breast cancer may improve outcomes for patients one day.
February 19, 2021
This week, more than 130 hospitals, research foundations, fundraising organizations and patient advocacy groups asked the Biden administration to put cancer patients first in the next stage of the rollout. The letter, which was signed by leaders at the UC Cancer Center, says research in the past year shows that COVID-19 patients with cancer have twice the death rate than those without cancer.
February 17, 2021
A researcher at the University of Cincinnati is studying whether electrical stimulation of the spinal cord can be helpful in treating certain psychiatric conditions, like depression.
February 9, 2021
Tesfaye Mersha, a geneticist at the University of Cincinnati and Cincinnati Children's Hospital Medical Center, says including African populations in genetics research is paving the way for a better understanding of the links between disease and genes in everyone, everywhere, because Africa holds more genomic diversity than any other continent.
October 12, 2020
In one of the first studies of its kind, a University of Cincinnati researcher is using a grant from the Ohio attorney general’s office to research the pharmacogenomics of opioid addiction. The grant was awarded to Caroline Freiermuth, MD, associate professor in the Department of Emergency Medicine at the UC College of Medicine, the principal investigator for the study. The initial year will be supported with $1.63 million from the attorney general’s office, secured through money collected from pharmaceutical companies involved in opioid lawsuits. Pharmacogenomics, a relatively new field, is the study of how genes affect a person's response to drugs.
August 28, 2020
Kristin Weghorn, a lab supervisor in the Division of Infectious Diseases at the UC College of Medicine describes the various research projects being conducted at UC around COVID-19.
November 24, 2020
University of Cincinnati researchers have discovered new clues into why some people with head and neck cancer respond to immunotherapy, while others don’t.